Results 181 to 190 of about 149,597 (269)

Microplastics Removal by Sustainable PVA/Bentonite Membranes: Morphological and Structural Evidence of the Retention Mechanism. [PDF]

ACS Omega
Dal Magro FS, Silvestre WP, Baldasso C.
europepmc   +1 more source

Formation Plan de Gestion des Données (PGD) - version 2

, 2019
Auzoux, Sandrine, Corbiere, Pauline, Dedieu, Laurence   +2 more
openaire   +1 more source

Plan directeur de formation de l'ENEF de Mbalmayo (Cameroun) : tome 1

, 2006
Peltier, Régis, Njoukam, Raphaël
openaire   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

POCUS in the Management of Complications with Barbed Polydioxanone (PDO) Threads in Aesthetic Medicine: Case Report. [PDF]

POCUS J
Setúbal RA, Solidonio RB, Martins LFB, Barbosa DAF, Bezerra TMM, Gondim DV, de Sousa LM.   +6 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Assessment of intra-operative bowel perfusion in children using indocyanine green: an exploratory study investigating its effect on surgical management. [PDF]

Pediatr Surg Int
Neville JJ, Vincent E, Gazzaneo M, Marinaro M, Nair A, Cirelli C, Privitera L, De Coppi P, Giuliani S.   +8 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source